Nathan Connell: Achieving Equity in Hemophilia Care by Reframing the Disease as Affecting Both Sexes
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on LinkedIn about a recent article by Alkistis Adramerina and Marina Economou, published in Journal of Clinical Medicine:
”Hemophilia is still often widely perceived as a ‘male disease,’ but this review challenges that paradigm.
Emerging data show that a substantial number of women and girls have clinically meaningful factor deficiencies and bleeding symptoms, yet remain underdiagnosed and undertreated.
The article highlights several critical gaps:
- Female patients are less likely to be followed in specialized hemophilia treatment centers
- Gynecologic and obstetric bleeding adds unique, underappreciated morbidity
- Evidence guiding management is limited due to underrepresentation in clinical trials and other types of studies
- Standard treatment principles apply, but care delivery is inconsistent
The authors argue for a shift toward proactive identification (including family-based screening), multidisciplinary care models, and intentional inclusion of women and girls in research.
Bottom line: Achieving equity in hemophilia care requires reframing the disease as affecting both sexes – and redesigning systems to reflect that reality.”
Title: Hemophilia’s Overlooked Female Face
Authors: Alkistis Adramerina, Marina Economou
Read the Full Article on Journal of Clinical Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders